Form 4: Gazelle Parent Director Receives Stock Grant
Insider Transaction (Form 4)
Maria Fardis, a Director of Gazelle Parent, Inc., received 37,653 shares of common stock on August 3, 2026.
Summary
- Grant/award: acquired 37,653 Stock Option (Right to Buy) on August 3, 2026; holds 37,653 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Maria Fardis — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Grant/award | Stock Option (Right to Buy) | 37,653 | — | — | 37,653 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Grant/award (37,653 shares) |
Keywords
insider transaction, Form 4, OBX, Obsidian Therapeutics, Inc., neutral, Maria Fardis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.